Screening for primary aldosteronism is underutilised in patients with chronic kidney disease.

ABSTRACT:

Background

Primary aldosteronism (PA) is the most common and potentially curable endocrine cause of secondary hypertension, and carries a worse prognosis than essential hypertension. Despite the high prevalence of hypertension in patients with chronic kidney disease (CKD), the screening rates for primary aldosteronism in CKD are unknown.

Methods

In this study, we retrospectively reviewed medical records of 1627 adults who presented to the nephrology clinics of 2 tertiary hospitals in Melbourne, Australia, between 2014 and 2019. In addition to assessing the pattern of screening, we also evaluated patient-specific factors associated with the decision to test for primary aldosteronism. Patients were excluded from the final analysis if they did not have CKD, had an organ transpl

SUBMITTER: Chauhan K 

PROVIDER: S-EPMC9300536 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature